Sang Cheol Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sang Cheol Kim has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Fotuhi Siahpirani
University of Tehran
1 shared publication - Anandkumar Surendrarao
Plant Biology Graduate Group, University of California, One Shields Ave., Davis, CA 95616-8680, U.S.A.
1 shared publication Ara Kwon
Division of Intractable Diseases Research, Department of Chronic Disease Convergence Research, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
1 shared publication- Bo-Young Kim
Division of Intractable Diseases Research, National Institute of Health, Cheongju, Republic of Korea; Korea National Stem Cell Bank, National Institute of Health, Cheongju, Republic of Korea
1 shared publication Brendan K. Riely
Department of Plant Pathology (E.L., B.K.R., N.C.-G., R.V.P., D.R.C) and
1 shared publicationByung Soo Park
Korea Disease Control and Prevention Agency Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, National Institute of Health Cheongju, 28159, Republic of
1 shared publication
Latest Publications
- Open Access
- 26 April 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1)
NeuroStream: An interactive platform for exploratory visualization and harmonization of multicohort brain MRI data
Motivation: Large-scale neuroimaging studies increasingly integrate brain MRI data from multiple cohorts and acquisition sites. Exploratory visualization and harmonization are essential for identifying batch effects, assessing preprocessing strategies, and preserving biologically meaningful variation. However, existing tools are often cohort-specific, rely on static visualizations, or separate harmonization from data exploration. Results: We present NeuroStream, an interactive application for real-time visualization and harmonization of multicohort brain MRI quantitative data. Built using the Streamlit framework, NeuroStream enables the exploration of quantitative imaging features derived from structural MRI along with demographic and clinical variables. The platform supports preprocessing and harmonization options, including log transformation, intracranial volume normalization, and ComBat-based batch correction, which can be compared interactively using dynamic visualizations. NeuroStream provides principal component analysis, distributional plots, and group comparison statistics. In addition, the platform supports covariate-adjusted regression-based evaluation of site effects and residual diagnostics, enabling quantitative and visual assessment of cohort-related variability across preprocessing settings. All visualizations presented in this manuscript were generated using transformed example datasets designed to illustrate the functionality of the platform, rather than to report original subject-level measurements, while NeuroStream itself supports direct analysis of user-provided tabular data. Using transformed example datasets derived from BICWALZS and KoGES multicohort MRI data, we demonstrate intuitive inspection of batch-related variance and harmonization outcomes without custom scripting. Availability and implementation: NeuroStream is implemented in Python and freely available at https://github.com/NIHxAI/NeuroStream.
- 26 April 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1)
Open AccessNeuroStream: An interactive platform for exploratory visualization and harmonization of multicohort brain MRI data
Motivation: Large-scale neuroimaging studies increasingly integrate brain MRI data from multiple cohorts and acquisition sites. Exploratory visualization and harmonization are essential for identifying batch effects, assessing preprocessing strategies, and preserving biologically meaningful variation. However, existing tools are often cohort-specific, rely on static visualizations, or separate harmonization from data exploration. Results: We present NeuroStream, an interactive application for real-time visualization and harmonization of multicohort brain MRI quantitative data. Built using the Streamlit framework, NeuroStream enables the exploration of quantitative imaging features derived from structural MRI along with demographic and clinical variables. The platform supports preprocessing and harmonization options, including log transformation, intracranial volume normalization, and ComBat-based batch correction, which can be compared interactively using dynamic visualizations. NeuroStream provides principal component analysis, distributional plots, and group comparison statistics. In addition, the platform supports covariate-adjusted regression-based evaluation of site effects and residual diagnostics, enabling quantitative and visual assessment of cohort-related variability across preprocessing settings. All visualizations presented in this manuscript were generated using transformed example datasets designed to illustrate the functionality of the platform, rather than to report original subject-level measurements, while NeuroStream itself supports direct analysis of user-provided tabular data. Using transformed example datasets derived from BICWALZS and KoGES multicohort MRI data, we demonstrate intuitive inspection of batch-related variance and harmonization outcomes without custom scripting. Availability and implementation: NeuroStream is implemented in Python and freely available at https://github.com/NIHxAI/NeuroStream.
- Open Access
- 5 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (49) , eadx8303
B cell–reactive neoantigens boost antitumor immunity
B cell involvement in neoantigen-driven antitumor immunity remains largely unexplored because of challenges in predicting B cell responses. Here, we developed a method to identify B cell epitopes by characterizing >437,000 peptides tested for IgG binding and >370 million B cell receptor (BCR) clones. Our single-cell BCR sequencing of pre– and post–severe acute respiratory syndrome coronavirus 2 vaccination validates the performance of this method. Mouse vaccination experiments demonstrate that B cell neoepitopes enhance immune responses, driving BCR expansion and tumor regression. Genomic analysis of >8000 The Cancer Genome Atlas (TCGA) samples reveals an inverse correlation between predicted B cell reactivity and mutation allele frequencies, indicating B cell–mediated neoantigen elimination. Applying our multiomics model to checkpoint blockade responses in 2074 patients highlights the clinical relevance of B cell neoepitope prediction. A meta-analysis of 11 personalized vaccine trials involving 1739 neoantigens suggests that incorporating B cell neoepitopes may improve vaccination efficacy. These results underscore the significance of B cell–reactive neoantigens in antitumor immunity.
- 5 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (49) , eadx8303
Open AccessB cell–reactive neoantigens boost antitumor immunity
B cell involvement in neoantigen-driven antitumor immunity remains largely unexplored because of challenges in predicting B cell responses. Here, we developed a method to identify B cell epitopes by characterizing >437,000 peptides tested for IgG binding and >370 million B cell receptor (BCR) clones. Our single-cell BCR sequencing of pre– and post–severe acute respiratory syndrome coronavirus 2 vaccination validates the performance of this method. Mouse vaccination experiments demonstrate that B cell neoepitopes enhance immune responses, driving BCR expansion and tumor regression. Genomic analysis of >8000 The Cancer Genome Atlas (TCGA) samples reveals an inverse correlation between predicted B cell reactivity and mutation allele frequencies, indicating B cell–mediated neoantigen elimination. Applying our multiomics model to checkpoint blockade responses in 2074 patients highlights the clinical relevance of B cell neoepitope prediction. A meta-analysis of 11 personalized vaccine trials involving 1739 neoantigens suggests that incorporating B cell neoepitopes may improve vaccination efficacy. These results underscore the significance of B cell–reactive neoantigens in antitumor immunity.
- Open Access
- 30 September 2022
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 20 (3) , e29
The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
Several studies have shown associations between irinotecan toxicity and UGT1A genetic variations in colorectal and lung cancer, but only limited data are available for gastric cancer patients. We evaluated the frequencies of UGT1A polymorphisms and their relationship with clinicopathologic parameters in 382 Korean gastric cancer patients. Polymorphisms of UGT1A1*6, UGT1A1*27, UGT1A1*28, UGT1A1*60, UGT1A7*2, UGT1A7*3, and UGT1A9*22 were genotyped by direct sequencing. In 98 patients treated with irinotecan-containing regimens, toxicity and response were compared according to the genotype. The UGT1A1*6 and UGT1A9*22 genotypes showed a higher prevalence in Korean gastric cancer patients, while the prevalence of the UG1A1*28 polymorphism was lower than in normal Koreans, as has been found in other studies of Asian populations. The incidence of severe diarrhea after irinotecan-containing treatment was more common in patients with the UGT1A1*6, UGT1A7*3, and UGT1A9*22 polymorphisms than in controls. The presence of the UGT1A1*6 allele also showed a significant association with grade III–IV neutropenia. Upon haplotype and diplotype analyses, almost every patient bearing the UGT1A1*6 or UGT1A7*3 variant also had the UGT1A9*22 polymorphism, and all severe manifestations of UGT1A polymorphism-associated toxicity were related to the UGT1A9*22 polymorphism. By genotyping UGT1A9*22 polymorphisms, we could identify high-risk gastric cancer patients receiving irinotecan-containing chemotherapy, who would experience severe toxicity. When treating high-risk patients with the UGT1A9*22 polymorphism, clinicians should closely monitor them for signs of severe toxicity such as intense diarrhea or neutropenia.
- 30 September 2022
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 20 (3) , e29
Open AccessThe UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
Several studies have shown associations between irinotecan toxicity and UGT1A genetic variations in colorectal and lung cancer, but only limited data are available for gastric cancer patients. We evaluated the frequencies of UGT1A polymorphisms and their relationship with clinicopathologic parameters in 382 Korean gastric cancer patients. Polymorphisms of UGT1A1*6, UGT1A1*27, UGT1A1*28, UGT1A1*60, UGT1A7*2, UGT1A7*3, and UGT1A9*22 were genotyped by direct sequencing. In 98 patients treated with irinotecan-containing regimens, toxicity and response were compared according to the genotype. The UGT1A1*6 and UGT1A9*22 genotypes showed a higher prevalence in Korean gastric cancer patients, while the prevalence of the UG1A1*28 polymorphism was lower than in normal Koreans, as has been found in other studies of Asian populations. The incidence of severe diarrhea after irinotecan-containing treatment was more common in patients with the UGT1A1*6, UGT1A7*3, and UGT1A9*22 polymorphisms than in controls. The presence of the UGT1A1*6 allele also showed a significant association with grade III–IV neutropenia. Upon haplotype and diplotype analyses, almost every patient bearing the UGT1A1*6 or UGT1A7*3 variant also had the UGT1A9*22 polymorphism, and all severe manifestations of UGT1A polymorphism-associated toxicity were related to the UGT1A9*22 polymorphism. By genotyping UGT1A9*22 polymorphisms, we could identify high-risk gastric cancer patients receiving irinotecan-containing chemotherapy, who would experience severe toxicity. When treating high-risk patients with the UGT1A9*22 polymorphism, clinicians should closely monitor them for signs of severe toxicity such as intense diarrhea or neutropenia.
- Open Access
- 29 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation
Human pluripotent stem cells (hPSCs) have promising therapeutic applications due to their infinite capacity for self-renewal and pluripotency. Genomic stability is imperative for the clinical use of hPSCs; however, copy number variation (CNV), especially recurrent CNV at 20q11.21, may contribute genomic instability of hPSCs. Furthermore, the effects of CNVs in hPSCs at the whole-transcriptome scale are poorly understood. This study aimed to examine the functional in vivo and in vitro effects of frequently detected CNVs at 20q11.21 during early-stage differentiation of hPSCs. Comprehensive transcriptome profiling of abnormal hPSCs revealed that the differential gene expression patterns had a negative effect on differentiation potential. Transcriptional heterogeneity identified by single-cell RNA sequencing (scRNA-seq) of embryoid bodies from two different isogenic lines of hPSCs revealed alterations in differentiated cell distributions compared with that of normal cells. RNA-seq analysis of 22 teratomas identified several differentially expressed lineage-specific markers in hPSCs with CNVs, consistent with the histological results of the altered ecto/meso/endodermal ratio due to CNVs. Our results suggest that CNV amplification contributes to cell proliferation, apoptosis, and cell fate specification. This work shows the functional consequences of recurrent genetic abnormalities and thereby provides evidence to support the development of cell-based applications.
- 29 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Open AccessFunctional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation
Human pluripotent stem cells (hPSCs) have promising therapeutic applications due to their infinite capacity for self-renewal and pluripotency. Genomic stability is imperative for the clinical use of hPSCs; however, copy number variation (CNV), especially recurrent CNV at 20q11.21, may contribute genomic instability of hPSCs. Furthermore, the effects of CNVs in hPSCs at the whole-transcriptome scale are poorly understood. This study aimed to examine the functional in vivo and in vitro effects of frequently detected CNVs at 20q11.21 during early-stage differentiation of hPSCs. Comprehensive transcriptome profiling of abnormal hPSCs revealed that the differential gene expression patterns had a negative effect on differentiation potential. Transcriptional heterogeneity identified by single-cell RNA sequencing (scRNA-seq) of embryoid bodies from two different isogenic lines of hPSCs revealed alterations in differentiated cell distributions compared with that of normal cells. RNA-seq analysis of 22 teratomas identified several differentially expressed lineage-specific markers in hPSCs with CNVs, consistent with the histological results of the altered ecto/meso/endodermal ratio due to CNVs. Our results suggest that CNV amplification contributes to cell proliferation, apoptosis, and cell fate specification. This work shows the functional consequences of recurrent genetic abnormalities and thereby provides evidence to support the development of cell-based applications.
- Open Access
- 31 December 2018
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 16 (4) , e36
COEX-Seq: Convert a Variety of Measurements of Gene Expression in RNA-Seq
Next generation sequencing (NGS), a high-throughput DNA sequencing technology, is widely used for molecular biological studies. In NGS, RNA-sequencing (RNA-Seq), which is a short-read massively parallel sequencing, is a major quantitative transcriptome tool for different transcriptome studies. To utilize the RNA-Seq data, various quantification and analysis methods have been developed to solve specific research goals, including identification of differentially expressed genes and detection of novel transcripts. Because of the accumulation of RNA-Seq data in the public databases, there is a demand for integrative analysis. However, the available RNA-Seq data are stored in different formats such as read count, transcripts per million, and fragments per kilobase million. This hinders the integrative analysis of the RNA-Seq data. To solve this problem, we have developed a web-based application using Shiny, COEX-seq (Convert a Variety of Measurements of Gene Expression in RNA-Seq) that easily converts data in a variety of measurement formats of gene expression used in most bioinformatic tools for RNA-Seq. It provides a workflow that includes loading data set, selecting measurement formats of gene expression, and identifying gene names. COEX-seq is freely available for academic purposes and can be run on Windows, Mac OS, and Linux operating systems. Source code, sample data sets, and supplementary documentation are available as well.
- 31 December 2018
- Published by Korea Genome Organization in Genomics & Informatics
- Vol. 16 (4) , e36
Open AccessCOEX-Seq: Convert a Variety of Measurements of Gene Expression in RNA-Seq
Next generation sequencing (NGS), a high-throughput DNA sequencing technology, is widely used for molecular biological studies. In NGS, RNA-sequencing (RNA-Seq), which is a short-read massively parallel sequencing, is a major quantitative transcriptome tool for different transcriptome studies. To utilize the RNA-Seq data, various quantification and analysis methods have been developed to solve specific research goals, including identification of differentially expressed genes and detection of novel transcripts. Because of the accumulation of RNA-Seq data in the public databases, there is a demand for integrative analysis. However, the available RNA-Seq data are stored in different formats such as read count, transcripts per million, and fragments per kilobase million. This hinders the integrative analysis of the RNA-Seq data. To solve this problem, we have developed a web-based application using Shiny, COEX-seq (Convert a Variety of Measurements of Gene Expression in RNA-Seq) that easily converts data in a variety of measurement formats of gene expression used in most bioinformatic tools for RNA-Seq. It provides a workflow that includes loading data set, selecting measurement formats of gene expression, and identifying gene names. COEX-seq is freely available for academic purposes and can be run on Windows, Mac OS, and Linux operating systems. Source code, sample data sets, and supplementary documentation are available as well.
- Open Access
- 14 July 2015
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 169 (1) , 233-265
Deep Sequencing of the Medicago truncatula Root Transcriptome Reveals a Massive and Early Interaction between Nodulation Factor and Ethylene Signals
Transcriptional reprogramming is regulated by Nod factor-induced ethylene signaling.
- 14 July 2015
- Published by Oxford University Press (OUP) in Plant Physiology
- Vol. 169 (1) , 233-265
Open AccessDeep Sequencing of the Medicago truncatula Root Transcriptome Reveals a Massive and Early Interaction between Nodulation Factor and Ethylene Signals
Transcriptional reprogramming is regulated by Nod factor-induced ethylene signaling.
- Open Access
- 1 May 2012
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 80 (5) , 1639-1649
Vitamin B 12 -Mediated Restoration of Defective Anaerobic Growth Leads to Reduced Biofilm Formation in Pseudomonas aeruginosa
Pseudomonas aeruginosa undergoes cell elongation and forms robust biofilms during anaerobic respiratory growth using nitrate (NO 3 − ) as an alternative electron acceptor. Understanding the mechanism of cell shape change induced upon anaerobiosis is crucial to the development of effective treatments against P. aeruginosa biofilm infection. Here, we uncovered the molecular basis of anaerobiosis-triggered cell elongation and identified vitamin B 12 to be a molecule that can reinstate defective anaerobic growth of P. aeruginosa . The ratio of total cellular DNA content to protein content was significantly decreased in the PAO1 strain grown under anaerobic conditions, indicating that DNA replication is impaired during anaerobic growth. Anaerobic growth of PAO1 reached a higher cell density in the presence of vitamin B 12 , an essential coenzyme of class II ribonucleotide reductase. In addition, cell morphology returned to a normal rod shape and transcription of stress-response genes was downregulated under the same anaerobic growth conditions. These results suggest that vitamin B 12 , the production of which was suppressed during anaerobic growth, can restore cellular machineries for DNA replication and therefore facilitate better anaerobic growth of P. aeruginosa with normal cell division. Importantly, biofilm formation was substantially decreased when grown with vitamin B 12 , further demonstrating that anaerobiosis-induced cell elongation is responsible for robust biofilm formation. Taken together, our data reveal mechanistic details of a morphological change that naturally occurs during anaerobic growth of P. aeruginosa and illustrates the ability of vitamin B 12 to modulate the biofilm-forming capacity of P. aeruginosa under such condition.
- 1 May 2012
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 80 (5) , 1639-1649
Open AccessVitamin B 12 -Mediated Restoration of Defective Anaerobic Growth Leads to Reduced Biofilm Formation in Pseudomonas aeruginosa
Pseudomonas aeruginosa undergoes cell elongation and forms robust biofilms during anaerobic respiratory growth using nitrate (NO 3 − ) as an alternative electron acceptor. Understanding the mechanism of cell shape change induced upon anaerobiosis is crucial to the development of effective treatments against P. aeruginosa biofilm infection. Here, we uncovered the molecular basis of anaerobiosis-triggered cell elongation and identified vitamin B 12 to be a molecule that can reinstate defective anaerobic growth of P. aeruginosa . The ratio of total cellular DNA content to protein content was significantly decreased in the PAO1 strain grown under anaerobic conditions, indicating that DNA replication is impaired during anaerobic growth. Anaerobic growth of PAO1 reached a higher cell density in the presence of vitamin B 12 , an essential coenzyme of class II ribonucleotide reductase. In addition, cell morphology returned to a normal rod shape and transcription of stress-response genes was downregulated under the same anaerobic growth conditions. These results suggest that vitamin B 12 , the production of which was suppressed during anaerobic growth, can restore cellular machineries for DNA replication and therefore facilitate better anaerobic growth of P. aeruginosa with normal cell division. Importantly, biofilm formation was substantially decreased when grown with vitamin B 12 , further demonstrating that anaerobiosis-induced cell elongation is responsible for robust biofilm formation. Taken together, our data reveal mechanistic details of a morphological change that naturally occurs during anaerobic growth of P. aeruginosa and illustrates the ability of vitamin B 12 to modulate the biofilm-forming capacity of P. aeruginosa under such condition.